(Q26750315)

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Helminth infections associated with multiple sclerosis induce regulatory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Mechanisms of tolerance to inhalant allergens: the relevance of a modified Th2 response to allergens from domestic animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Regulatory T cells in infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Regulatory T cells and immune tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Translatability of helminth therapy in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

The hookworm pharmacopoeia for inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Immunomodulation by helminth parasites: defining mechanisms and mediators

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Diet, metabolites, and "western-lifestyle" inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Regulatory B-cell induction by helminths: implications for allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Worms as therapeutic agents for allergy and asthma: understanding why benefits in animal studies have not translated into clinical success

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

The impact of parasite infections on the course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

The therapeutic helminth?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Helminth therapy for organic diseases?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Autoimmune disease and parasitic infections in Nigerians.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Parasitic helminths: a pharmacopeia of anti-inflammatory molecules.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Systemic impact of intestinal helminth infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Effect of helminth-induced immunity on infections with microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Immune regulation by helminth parasites: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Helminth-derived immunomodulators: can understanding the worm produce the pill?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Human allergy and geohelminth infections: a review of the literature and a proposed conceptual model to guide the investigation of possible causal associations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Elevated cellular immune responses and interferon-gamma release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

T-helper 17 cells are associated with pathology in human schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Helminths and immunological tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Experimental hookworm infection: a randomized placebo-controlled trial in asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Trichuris suisova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Atopy and current intestinal parasite infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Not all parasites are protective

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Clinical trials of helminth therapy in autoimmune diseases: rationale and findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Identifying the immunomodulatory components of helminths

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Helminth infections and host immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Trichuris suis therapy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Inverse association between skin response to aeroallergens and Schistosoma mansoni infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

T-cell regulation in helminth parasite infections: implications for inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Helminth infections: the great neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Human helminth therapy to treat inflammatory disorders - where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Do antenatal parasite infections devalue childhood vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

It's time to dispel the myth of "asymptomatic" schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Schistosome infection intensity is inversely related to auto-reactive antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

The rise of childhood type 1 diabetes in the 20th century.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

Regulatory T cell subsets in filarial infection and their function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2016.04.024

7 January 2021

10.1016/J.CMI.2016.04.024

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2719434

2719434

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference